Radiopharm Theranostics Files July 2025 Update (6-K)
Ticker: RDPTF · Form: 6-K · Filed: Jul 28, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
RADIOPHARM THERANOSTICS LTD (RPTX) filed a 6-K for July 2025, confirming 20-F annual report filing.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on July 28, 2025, reporting information for the month of July 2025. The company is a foreign private issuer and is providing an update to the SEC. The filing indicates the company will file its annual reports under Form 20-F.
Why It Matters
This filing provides a routine update from Radiopharm Theranostics, a foreign private issuer, to the SEC, indicating their ongoing compliance and reporting procedures.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- 20250728 (date) — Filing Date
- July 2025 (date) — Reporting Period
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is Radiopharm Theranostics Limited.
What is the SEC file number for this registrant?
The SEC file number is 001-41621.
For which month is this report being filed?
This report is being filed for the month of July 2025.
Does Radiopharm Theranostics file annual reports under Form 20-F or 40-F?
Radiopharm Theranostics indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 28, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).